Pulmonx share price logo

Pulmonx

NASDAQ: LUNG

$1.85

as on

Pulmonx Stock Performance

as on September 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.81
    $1.94
    downward going graph

    2.16%

    Downside

    4.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.13
    $2.89
    downward going graph

    38.92%

    Downside

    56.22%

    Upside

    downward going graph

Pulmonx share price movements today

Previous Close
$1.85
Open
$1.94
Volume
310.0K
Market Cap
$89.3M
Day's Low - High
$1.81 - $1.94
52 Week Low - High
$1.13 - $2.89

Pulmonx Historical Returns

1 Month Return
-13.16 %
3 Month Return
+ 38.46 %
1 Year Return
+ 22.98 %
3 Year Return
-80.98 %
5 Year Return
-94.9 %

Pulmonx Stock Fundamentals & Key Indicators

Check Pulmonx market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.3M

EPS (TTM)

-1.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.72

Industry PE ratio

-1.93

PEG Ratio

-0.07751668031214852

EBITDA

-43.1M

Revenue (TTM)

87.4M

Profit Margin

77.06%

Return On Equity TTM

-96.66%

Pulmonx Stock Valuation

Track how Pulmonx P/E has moved over time to understand its valuation trends.

Pulmonx in the last 5 years

  • Overview

  • Trends

Lowest (-23.81x)

December 31, 2021

Industry (-1.93x)

December 31, 2025

Today (-1.66x)

December 31, 2025

Highest (-1.66x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.66x

Pulmonx vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$89.3M-94.9%-1.7277.06%NA
BUY$49.7B-28.71%49.5377.98%NA
BUY$120.5B-29.93%22.4766.69%308.48%
BUY$187.5B-18.3%34.1511.65%235.02999999999997%
BUY$116.3B-0.18%28.4165.17%1.26%

Stock Returns calculator for Pulmonx Stock including INR - Dollar returns

The Pulmonx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pulmonx investment value today

Current value as on today

₹1,24,361

Returns

₹24,361

(+24.36%)

Returns from Pulmonx Stock

₹14,907 (+14.91%)

Dollar Impact

₹9,454 (+9.45%)

Analyst Recommendation on Pulmonx Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Pulmonx. Average target price of $3.4

Pulmonx Share Price Target

Get share price movements and forecasts by analysts on Pulmonx.

What analysts predicted

45.59%UPSIDE

Target Price

$3.4

Current Price

$1.85

Analyzed by

4 Analysts

Target

$3.40

Pulmonx target price $3.4, a slight upside of 45.59% compared to current price of $1.85. According to 4 analysts rating.

Indian Investors' Interest in Pulmonx Stock

Search interest for Pulmonx Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Pulmonx Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
18
20
20
23
22
23
21
22
20
22
Gross Profit
13
15
15
17
16
17
16
17
16
17
Operating Income
-14
-15
-14
-13
-14
-14
-14
-9
-12
-9
EBITDA
-12
-13
-12
-12
-14
-13
-12
-9
-12
-8
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-13
-15
-13
-13
-14
-14
-13
-10
-13
-9
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-13
-15
-14
-13
-14
-15
-13
-10
-13
-10
Net Profit Margin
74.14%
73.65%
73.70%
74.02%
72.51%
72.11%
74.65%
77.62%
77.94%
77.97%

Pulmonx Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
20
32
32
48
53
68
83
90
Gross Profit
12
22
21
35
39
50
62
67
Operating Income
-15
-17
-32
-47
-58
-61
-57
-53
EBITDA
-15
-16
-28
-46
-55
-55
-50
-49
Interest Expense
2
2
3
0
1
3
3
3
Depreciation
0
1
0
0
1
1
1
1
Income Before Tax
-18
-20
-32
-48
-58
-60
-55
-53
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-18
-20
-32
-48
-58
-60
-56
-54
Net Profit Margin
61.42%
68.77%
64.77%
73.59%
74.29%
73.90%
74.00%
74.19%

Pulmonx Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-15
-14
-13
-14
-15
-13
-10
-13
-10
Operating Cash Flow
-11
-5
-7
-6
-13
-3
-8
-7
-10
-5
Investing Cash Flow
-2
0
6
14
16
5
8
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
2
0
Change in Cash
-13
-6
0
7
3
0
1
-6
-8
-5

Pulmonx Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-20
-32
-48
-58
-60
-56
-54
Operating Cash Flow
-18
-20
-30
-41
-45
-37
-31
-32
Investing Cash Flow
0
-14
12
-46
-4
-2
17
30
Financing Cash Flow
12
45
234
4
2
21
1
0
Change in Cash
-5
10
217
-83
-46
-18
-12
-1

Mutual Funds that own Pulmonx Stock

Check out the Mutual Funds with significant holdings in Pulmonx.

Funds
Holdings
Shares Held
PRIMECAP Odyssey Funds
8.386836%
3602001
VANGUARD INDEX FUNDS
3.703273%
1590492
Fidelity Salem Street Trust
0.920858%
395493
VANGUARD EXPLORER FUND
0.891984%
383092
Fidelity Concord Street Trust
0.750605%
322372

Global Institutional Holdings in Pulmonx

Funds
Holdings
Theofanis Kolokotrones
10.74%
Vanguard
3.76%
iShares
0.32%
Bridgeway
0.08%

Insights on Pulmonx

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 20.58M → 22.75M (in $), with an average increase of 9.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LUNG has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -13.65M → -10.08M (in $), with an average increase of 35.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 15.3% return, outperforming this stock by 97.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LUNG stock has moved down by -16.3%

About Pulmonx

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
OrganisationPulmonx
Headquarters700 Chesapeake Drive, Redwood City, CA, United States, 94063
IndustryMedical Devices
CEOMr. Glendon E. French
E-voting on sharesClick here to vote

Key Management of Pulmonx

Name

Title

Mr. Glendon E. French

CEO, President & Director

Dr. Derrick Sung Ph.D.

CFO & COO

Mr. David A. Lehman J.D.

General Counsel & Secretary

Ms. Marcee M. Maroney

Vice President of Marketing

Mr. Geoffrey Beran Rose

Chief Commercial Officer

Mr. John B. McKune

VP of Finance & Corporate Controller

Mr. Srikanth Radhakrishnan

Chief Science & Technology Officer

Mr. Jérôme Erath

Senior VP & GM of International

Dr. Narinder S. Shargill Ph.D.

Senior Vice President of Global Medical & Clinical Affairs

FAQs

What is Pulmonx share price today?

Pulmonx share price today is $1.85 as on at the close of the market. Pulmonx share today touched a day high of $1.94 and a low of $1.81.

What is the 52 week high and 52 week low for Pulmonx share?

Pulmonx share touched a 52 week high of $2.89 on and a 52 week low of $1.13 on . Pulmonx stock price today i.e. is closed at $1.85,which is 35.99% down from its 52 week high and 63.72% up from its 52 week low.

What is Pulmonx's market capitalisation today?

Pulmonx market capitalisation is $0.00T as on .

How to invest in Pulmonx Stock (LUNG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pulmonx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Shares that will get you 0.8108 shares as per Pulmonx share price of $1.85 per share as on September 12, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pulmonx Stock (LUNG) from India?

Indian investors can start investing in Pulmonx (LUNG) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Pulmonx stock (as per the Rupee-Dollar exchange rate as on ). Based on Pulmonx share’s latest price of $1.85 as on September 12, 2026 at 8:45 am IST, you will get 5.4054 shares of Pulmonx. Learn more about fractional shares .

What are the returns that Pulmonx has given to Indian investors in the last 5 years?

Pulmonx stock has given -94.9% share price returns and 29.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?